Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery Article Swipe

PDF

Benjamin G. Cohen , Francine Chingcuanco , Jingwei Zhang , Natalie M. Reid , Victoria Lee , Jonathan Hong , Efthymios Deliargyris , William V. Padula ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1007/s40256-023-00587-4

Related Topics

Concepts

Medicine Ticagrelor Perioperative Cohort Cost effectiveness Antithrombotic Surgery Anesthesia Clopidogrel Internal medicine Aspirin Risk analysis (engineering)

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1007/s40256-023-00587-4
PDF: https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf
OA Status: hybrid
Cited By: 2
References: 35
Related Works: 10
OpenAlex ID: https://openalex.org/W4377093184

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4377093184

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1007/s40256-023-00587-4

Digital Object Identifier
Title: Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-05-19

Full publication date if available
Authors: Benjamin G. Cohen, Francine Chingcuanco, Jingwei Zhang, Natalie M. Reid, Victoria Lee, Jonathan Hong, Efthymios Deliargyris, William V. Padula

List of authors in order
Landing page: https://doi.org/10.1007/s40256-023-00587-4

Publisher landing page
PDF URL: https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf

Direct OA link when available
Concepts: Medicine, Ticagrelor, Perioperative, Cohort, Cost effectiveness, Antithrombotic, Surgery, Anesthesia, Clopidogrel, Internal medicine, Aspirin, Risk analysis (engineering)

Top concepts (fields/topics) attached by OpenAlex
Cited by: 2

Total citation count in OpenAlex
Citations by year (recent): 2025: 2

Per-year citation counts (last 5 years)
References (count): 35

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4377093184
doi	https://doi.org/10.1007/s40256-023-00587-4
ids.doi	https://doi.org/10.1007/s40256-023-00587-4
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/37204675
ids.openalex	https://openalex.org/W4377093184
fwci	0.67143376
mesh[0].qualifier_ui
mesh[0].descriptor_ui	D006801
mesh[0].is_major_topic	False
mesh[0].qualifier_name
mesh[0].descriptor_name	Humans
mesh[1].qualifier_ui	Q000009
mesh[1].descriptor_ui	D000077486
mesh[1].is_major_topic	False
mesh[1].qualifier_name	adverse effects
mesh[1].descriptor_name	Ticagrelor
mesh[2].qualifier_ui	Q000009
mesh[2].descriptor_ui	D010975
mesh[2].is_major_topic	True
mesh[2].qualifier_name	adverse effects
mesh[2].descriptor_name	Platelet Aggregation Inhibitors
mesh[3].qualifier_ui	Q000009
mesh[3].descriptor_ui	D005343
mesh[3].is_major_topic	False
mesh[3].qualifier_name	adverse effects
mesh[3].descriptor_name	Fibrinolytic Agents
mesh[4].qualifier_ui
mesh[4].descriptor_ui	D003362
mesh[4].is_major_topic	False
mesh[4].qualifier_name
mesh[4].descriptor_name	Cost-Benefit Analysis
mesh[5].qualifier_ui	Q000139
mesh[5].descriptor_ui	D006470
mesh[5].is_major_topic	False
mesh[5].qualifier_name	chemically induced
mesh[5].descriptor_name	Hemorrhage
mesh[6].qualifier_ui	Q000009
mesh[6].descriptor_ui	D001026
mesh[6].is_major_topic	False
mesh[6].qualifier_name	adverse effects
mesh[6].descriptor_name	Coronary Artery Bypass
mesh[7].qualifier_ui	Q000188
mesh[7].descriptor_ui	D054058
mesh[7].is_major_topic	True
mesh[7].qualifier_name	drug therapy
mesh[7].descriptor_name	Acute Coronary Syndrome
mesh[8].qualifier_ui	Q000601
mesh[8].descriptor_ui	D054058
mesh[8].is_major_topic	True
mesh[8].qualifier_name	surgery
mesh[8].descriptor_name	Acute Coronary Syndrome
mesh[9].qualifier_ui
mesh[9].descriptor_ui	D006801
mesh[9].is_major_topic	False
mesh[9].qualifier_name
mesh[9].descriptor_name	Humans
mesh[10].qualifier_ui	Q000009
mesh[10].descriptor_ui	D000077486
mesh[10].is_major_topic	False
mesh[10].qualifier_name	adverse effects
mesh[10].descriptor_name	Ticagrelor
mesh[11].qualifier_ui	Q000009
mesh[11].descriptor_ui	D010975
mesh[11].is_major_topic	True
mesh[11].qualifier_name	adverse effects
mesh[11].descriptor_name	Platelet Aggregation Inhibitors
mesh[12].qualifier_ui	Q000009
mesh[12].descriptor_ui	D005343
mesh[12].is_major_topic	False
mesh[12].qualifier_name	adverse effects
mesh[12].descriptor_name	Fibrinolytic Agents
mesh[13].qualifier_ui
mesh[13].descriptor_ui	D003362
mesh[13].is_major_topic	False
mesh[13].qualifier_name
mesh[13].descriptor_name	Cost-Benefit Analysis
mesh[14].qualifier_ui	Q000139
mesh[14].descriptor_ui	D006470
mesh[14].is_major_topic	False
mesh[14].qualifier_name	chemically induced
mesh[14].descriptor_name	Hemorrhage
mesh[15].qualifier_ui	Q000009
mesh[15].descriptor_ui	D001026
mesh[15].is_major_topic	False
mesh[15].qualifier_name	adverse effects
mesh[15].descriptor_name	Coronary Artery Bypass
mesh[16].qualifier_ui	Q000188
mesh[16].descriptor_ui	D054058
mesh[16].is_major_topic	True
mesh[16].qualifier_name	drug therapy
mesh[16].descriptor_name	Acute Coronary Syndrome
mesh[17].qualifier_ui	Q000601
mesh[17].descriptor_ui	D054058
mesh[17].is_major_topic	True
mesh[17].qualifier_name	surgery
mesh[17].descriptor_name	Acute Coronary Syndrome
type	article
title	Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery
biblio.issue	4
biblio.volume	23
biblio.last_page	440
biblio.first_page	429
topics[0].id	https://openalex.org/T11064
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9997000098228455
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2705
topics[0].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[0].display_name	Antiplatelet Therapy and Cardiovascular Diseases
topics[1].id	https://openalex.org/T11055
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9988999962806702
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2746
topics[1].subfield.display_name	Surgery
topics[1].display_name	Cardiac and Coronary Surgery Techniques
topics[2].id	https://openalex.org/T10198
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9973999857902527
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2705
topics[2].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[2].display_name	Heart Failure Treatment and Management
is_xpac	False
apc_list.value	3390
apc_list.currency	EUR
apc_list.value_usd	4390
apc_paid.value	3390
apc_paid.currency	EUR
apc_paid.value_usd	4390
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9526680707931519
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2780890252
concepts[1].level	4
concepts[1].score	0.782191812992096
concepts[1].wikidata	https://www.wikidata.org/wiki/Q420542
concepts[1].display_name	Ticagrelor
concepts[2].id	https://openalex.org/C31174226
concepts[2].level	2
concepts[2].score	0.7395490407943726
concepts[2].wikidata	https://www.wikidata.org/wiki/Q64855140
concepts[2].display_name	Perioperative
concepts[3].id	https://openalex.org/C72563966
concepts[3].level	2
concepts[3].score	0.49793505668640137
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1303415
concepts[3].display_name	Cohort
concepts[4].id	https://openalex.org/C3019080777
concepts[4].level	2
concepts[4].score	0.4710923135280609
concepts[4].wikidata	https://www.wikidata.org/wiki/Q1754768
concepts[4].display_name	Cost effectiveness
concepts[5].id	https://openalex.org/C2777015399
concepts[5].level	2
concepts[5].score	0.4149194359779358
concepts[5].wikidata	https://www.wikidata.org/wiki/Q4775337
concepts[5].display_name	Antithrombotic
concepts[6].id	https://openalex.org/C141071460
concepts[6].level	1
concepts[6].score	0.3911226987838745
concepts[6].wikidata	https://www.wikidata.org/wiki/Q40821
concepts[6].display_name	Surgery
concepts[7].id	https://openalex.org/C42219234
concepts[7].level	1
concepts[7].score	0.32627394795417786
concepts[7].wikidata	https://www.wikidata.org/wiki/Q131130
concepts[7].display_name	Anesthesia
concepts[8].id	https://openalex.org/C2777849778
concepts[8].level	3
concepts[8].score	0.2414766550064087
concepts[8].wikidata	https://www.wikidata.org/wiki/Q410237
concepts[8].display_name	Clopidogrel
concepts[9].id	https://openalex.org/C126322002
concepts[9].level	1
concepts[9].score	0.23775634169578552
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[9].display_name	Internal medicine
concepts[10].id	https://openalex.org/C2777628954
concepts[10].level	2
concepts[10].score	0.1342945098876953
concepts[10].wikidata	https://www.wikidata.org/wiki/Q18216
concepts[10].display_name	Aspirin
concepts[11].id	https://openalex.org/C112930515
concepts[11].level	1
concepts[11].score	0.0
concepts[11].wikidata	https://www.wikidata.org/wiki/Q4389547
concepts[11].display_name	Risk analysis (engineering)
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9526680707931519
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/ticagrelor
keywords[1].score	0.782191812992096
keywords[1].display_name	Ticagrelor
keywords[2].id	https://openalex.org/keywords/perioperative
keywords[2].score	0.7395490407943726
keywords[2].display_name	Perioperative
keywords[3].id	https://openalex.org/keywords/cohort
keywords[3].score	0.49793505668640137
keywords[3].display_name	Cohort
keywords[4].id	https://openalex.org/keywords/cost-effectiveness
keywords[4].score	0.4710923135280609
keywords[4].display_name	Cost effectiveness
keywords[5].id	https://openalex.org/keywords/antithrombotic
keywords[5].score	0.4149194359779358
keywords[5].display_name	Antithrombotic
keywords[6].id	https://openalex.org/keywords/surgery
keywords[6].score	0.3911226987838745
keywords[6].display_name	Surgery
keywords[7].id	https://openalex.org/keywords/anesthesia
keywords[7].score	0.32627394795417786
keywords[7].display_name	Anesthesia
keywords[8].id	https://openalex.org/keywords/clopidogrel
keywords[8].score	0.2414766550064087
keywords[8].display_name	Clopidogrel
keywords[9].id	https://openalex.org/keywords/internal-medicine
keywords[9].score	0.23775634169578552
keywords[9].display_name	Internal medicine
keywords[10].id	https://openalex.org/keywords/aspirin
keywords[10].score	0.1342945098876953
keywords[10].display_name	Aspirin
language	en
locations[0].id	doi:10.1007/s40256-023-00587-4
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S151621711
locations[0].source.issn	1175-3277, 1179-187X
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	1175-3277
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	American Journal of Cardiovascular Drugs
locations[0].source.host_organization	https://openalex.org/P4310320330
locations[0].source.host_organization_name	Adis, Springer Healthcare
locations[0].source.host_organization_lineage	https://openalex.org/P4310320330, https://openalex.org/P4310319965
locations[0].source.host_organization_lineage_names	Adis, Springer Healthcare, Springer Nature
locations[0].license	cc-by-nc
locations[0].pdf_url	https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	American Journal of Cardiovascular Drugs
locations[0].landing_page_url	https://doi.org/10.1007/s40256-023-00587-4
locations[1].id	pmid:37204675
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	American journal of cardiovascular drugs : drugs, devices, and other interventions
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/37204675
locations[2].id	pmh:oai:pubmedcentral.nih.gov:10328880
locations[2].is_oa	True
locations[2].source.id	https://openalex.org/S2764455111
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	PubMed Central
locations[2].source.host_organization	https://openalex.org/I1299303238
locations[2].source.host_organization_name	National Institutes of Health
locations[2].source.host_organization_lineage	https://openalex.org/I1299303238
locations[2].license	cc-by-nc
locations[2].pdf_url	https://pmc.ncbi.nlm.nih.gov/articles/PMC10328880/pdf/40256_2023_Article_587.pdf
locations[2].version	submittedVersion
locations[2].raw_type	Text
locations[2].license_id	https://openalex.org/licenses/cc-by-nc
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name	Am J Cardiovasc Drugs
locations[2].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/10328880
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A5052502337
authorships[0].author.orcid
authorships[0].author.display_name	Benjamin G. Cohen
authorships[0].affiliations[0].raw_affiliation_string	Stage Analytics, Duluth, USA
authorships[0].author_position	first
authorships[0].raw_author_name	Benjamin G. Cohen
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	Stage Analytics, Duluth, USA
authorships[1].author.id	https://openalex.org/A5071878173
authorships[1].author.orcid
authorships[1].author.display_name	Francine Chingcuanco
authorships[1].affiliations[0].raw_affiliation_string	Stage Analytics, Duluth, USA
authorships[1].author_position	middle
authorships[1].raw_author_name	Francine Chingcuanco
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Stage Analytics, Duluth, USA
authorships[2].author.id	https://openalex.org/A5100434258
authorships[2].author.orcid	https://orcid.org/0000-0001-9696-7635
authorships[2].author.display_name	Jingwei Zhang
authorships[2].countries	US
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210145424
authorships[2].affiliations[0].raw_affiliation_string	CytoSorbents Corporation, Princeton, USA
authorships[2].institutions[0].id	https://openalex.org/I4210145424
authorships[2].institutions[0].ror	https://ror.org/04zmpx795
authorships[2].institutions[0].type	company
authorships[2].institutions[0].lineage	https://openalex.org/I4210145424
authorships[2].institutions[0].country_code	US
authorships[2].institutions[0].display_name	CytoSorbents (United States)
authorships[2].author_position	middle
authorships[2].raw_author_name	Jingwei Zhang
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	CytoSorbents Corporation, Princeton, USA
authorships[3].author.id	https://openalex.org/A5029819033
authorships[3].author.orcid
authorships[3].author.display_name	Natalie M. Reid
authorships[3].affiliations[0].raw_affiliation_string	Stage Analytics, Duluth, USA
authorships[3].author_position	middle
authorships[3].raw_author_name	Natalie M. Reid
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Stage Analytics, Duluth, USA
authorships[4].author.id	https://openalex.org/A5080854123
authorships[4].author.orcid	https://orcid.org/0000-0001-9578-3260
authorships[4].author.display_name	Victoria Lee
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210145424
authorships[4].affiliations[0].raw_affiliation_string	CytoSorbents Corporation, Princeton, USA
authorships[4].institutions[0].id	https://openalex.org/I4210145424
authorships[4].institutions[0].ror	https://ror.org/04zmpx795
authorships[4].institutions[0].type	company
authorships[4].institutions[0].lineage	https://openalex.org/I4210145424
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	CytoSorbents (United States)
authorships[4].author_position	middle
authorships[4].raw_author_name	Victoria Lee
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	CytoSorbents Corporation, Princeton, USA
authorships[5].author.id	https://openalex.org/A5008335380
authorships[5].author.orcid
authorships[5].author.display_name	Jonathan Hong
authorships[5].countries	CA
authorships[5].affiliations[0].institution_ids	https://openalex.org/I2800567748, https://openalex.org/I46247651
authorships[5].affiliations[0].raw_affiliation_string	St. Boniface Hospital, University of Manitoba, Winnipeg, Canada
authorships[5].institutions[0].id	https://openalex.org/I2800567748
authorships[5].institutions[0].ror	https://ror.org/02xerpt86
authorships[5].institutions[0].type	education
authorships[5].institutions[0].lineage	https://openalex.org/I2800567748
authorships[5].institutions[0].country_code	CA
authorships[5].institutions[0].display_name	St. Boniface Hospital
authorships[5].institutions[1].id	https://openalex.org/I46247651
authorships[5].institutions[1].ror	https://ror.org/02gfys938
authorships[5].institutions[1].type	education
authorships[5].institutions[1].lineage	https://openalex.org/I46247651
authorships[5].institutions[1].country_code	CA
authorships[5].institutions[1].display_name	University of Manitoba
authorships[5].author_position	middle
authorships[5].raw_author_name	Jonathan Hong
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	St. Boniface Hospital, University of Manitoba, Winnipeg, Canada
authorships[6].author.id	https://openalex.org/A5065347832
authorships[6].author.orcid	https://orcid.org/0000-0002-1893-7024
authorships[6].author.display_name	Efthymios Deliargyris
authorships[6].countries	US
authorships[6].affiliations[0].institution_ids	https://openalex.org/I4210145424
authorships[6].affiliations[0].raw_affiliation_string	CytoSorbents Corporation, Princeton, USA
authorships[6].institutions[0].id	https://openalex.org/I4210145424
authorships[6].institutions[0].ror	https://ror.org/04zmpx795
authorships[6].institutions[0].type	company
authorships[6].institutions[0].lineage	https://openalex.org/I4210145424
authorships[6].institutions[0].country_code	US
authorships[6].institutions[0].display_name	CytoSorbents (United States)
authorships[6].author_position	middle
authorships[6].raw_author_name	Efthymios N. Deliargyris
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	CytoSorbents Corporation, Princeton, USA
authorships[7].author.id	https://openalex.org/A5082725876
authorships[7].author.orcid
authorships[7].author.display_name	William V. Padula
authorships[7].countries	US
authorships[7].affiliations[0].institution_ids	https://openalex.org/I1174212
authorships[7].affiliations[0].raw_affiliation_string	Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California, Los Angeles, USA
authorships[7].affiliations[1].institution_ids	https://openalex.org/I1174212, https://openalex.org/I4210167432
authorships[7].affiliations[1].raw_affiliation_string	The Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, USC Schaeffer Center, Los Angeles, USA
authorships[7].affiliations[2].raw_affiliation_string	Stage Analytics, Duluth, USA
authorships[7].institutions[0].id	https://openalex.org/I4210167432
authorships[7].institutions[0].ror	https://ror.org/05tew9254
authorships[7].institutions[0].type	nonprofit
authorships[7].institutions[0].lineage	https://openalex.org/I4210167432
authorships[7].institutions[0].country_code	US
authorships[7].institutions[0].display_name	Center for Policy Analysis
authorships[7].institutions[1].id	https://openalex.org/I1174212
authorships[7].institutions[1].ror	https://ror.org/03taz7m60
authorships[7].institutions[1].type	education
authorships[7].institutions[1].lineage	https://openalex.org/I1174212
authorships[7].institutions[1].country_code	US
authorships[7].institutions[1].display_name	University of Southern California
authorships[7].author_position	last
authorships[7].raw_author_name	William V. Padula
authorships[7].is_corresponding	True
authorships[7].raw_affiliation_strings	Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California, Los Angeles, USA, Stage Analytics, Duluth, USA, The Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, USC Schaeffer Center, Los Angeles, USA
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11064
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9997000098228455
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2705
primary_topic.subfield.display_name	Cardiology and Cardiovascular Medicine
primary_topic.display_name	Antiplatelet Therapy and Cardiovascular Diseases
related_works	https://openalex.org/W2802232330, https://openalex.org/W4318820671, https://openalex.org/W2037327849, https://openalex.org/W2295055355, https://openalex.org/W2911330885, https://openalex.org/W2584710856, https://openalex.org/W2578926377, https://openalex.org/W2513748005, https://openalex.org/W3087029252, https://openalex.org/W2921627848
cited_by_count	2
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	2
locations_count	3
best_oa_location.id	doi:10.1007/s40256-023-00587-4
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S151621711
best_oa_location.source.issn	1175-3277, 1179-187X
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	1175-3277
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	American Journal of Cardiovascular Drugs
best_oa_location.source.host_organization	https://openalex.org/P4310320330
best_oa_location.source.host_organization_name	Adis, Springer Healthcare
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320330, https://openalex.org/P4310319965
best_oa_location.source.host_organization_lineage_names	Adis, Springer Healthcare, Springer Nature
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	American Journal of Cardiovascular Drugs
best_oa_location.landing_page_url	https://doi.org/10.1007/s40256-023-00587-4
primary_location.id	doi:10.1007/s40256-023-00587-4
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S151621711
primary_location.source.issn	1175-3277, 1179-187X
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	1175-3277
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	American Journal of Cardiovascular Drugs
primary_location.source.host_organization	https://openalex.org/P4310320330
primary_location.source.host_organization_name	Adis, Springer Healthcare
primary_location.source.host_organization_lineage	https://openalex.org/P4310320330, https://openalex.org/P4310319965
primary_location.source.host_organization_lineage_names	Adis, Springer Healthcare, Springer Nature
primary_location.license	cc-by-nc
primary_location.pdf_url	https://link.springer.com/content/pdf/10.1007/s40256-023-00587-4.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	American Journal of Cardiovascular Drugs
primary_location.landing_page_url	https://doi.org/10.1007/s40256-023-00587-4
publication_date	2023-05-19
publication_year	2023
referenced_works	https://openalex.org/W3003299879, https://openalex.org/W1794967778, https://openalex.org/W2597115850, https://openalex.org/W4200218534, https://openalex.org/W2923013365, https://openalex.org/W2030017437, https://openalex.org/W2096876696, https://openalex.org/W1986294961, https://openalex.org/W4281565659, https://openalex.org/W3093769482, https://openalex.org/W2914901994, https://openalex.org/W4206439276, https://openalex.org/W4281920016, https://openalex.org/W2980729639, https://openalex.org/W2763912732, https://openalex.org/W2612601033, https://openalex.org/W2626566926, https://openalex.org/W3101402527, https://openalex.org/W3097769974, https://openalex.org/W2035359991, https://openalex.org/W2064377485, https://openalex.org/W2905492457, https://openalex.org/W2084773259, https://openalex.org/W2149999848, https://openalex.org/W1996162793, https://openalex.org/W2885993136, https://openalex.org/W2790233912, https://openalex.org/W3191004998, https://openalex.org/W2174429140, https://openalex.org/W2765502370, https://openalex.org/W3104566486, https://openalex.org/W2889751570, https://openalex.org/W4200062714, https://openalex.org/W2607768916, https://openalex.org/W4200166811
referenced_works_count	35
abstract_inverted_index
cited_by_percentile_year.max	97
cited_by_percentile_year.min	95
corresponding_author_ids	https://openalex.org/A5052502337, https://openalex.org/A5082725876
countries_distinct_count	2
institutions_distinct_count	8
corresponding_institution_ids	https://openalex.org/I1174212, https://openalex.org/I4210167432
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5699999928474426
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.67471793
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False